High materiality7/10
Adaptive Biotechnologies price target raised to $25 from $22 at Guggenheim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises ADPT PT to 25; current price 22.56; upside potential.
- PT 25 vs price 22.56; bullish setup.
Key facts
- 01
Target: $25
- 02
Posted price: $22.56
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.